Related Experiment Video
Updated: Oct 15, 2026
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Stage T1 adenocarcinoma of the urinary bladder--complete response after transurethral resection and intravesical
1Department of Urology, Sahlgrenska University Hospital, Göteborg, Sweden.
Objective:
To report the results of treatment of adenocarcinoma of the urinary bladder with transurethral resection and intravesical bacillus Calmette-Guerin (BCG).
Methods:
Out of 183 patients in our department treated with BCG between 1992 and 1996, three patients had adenocarcinoma, stage T1.
Results:
All three patients had normal cystoscopy and negative cytology 53-82 months after the start of treatment.
Conclusions:
BCG appears to be effective not only in the treatment of transitional cell carcinoma, but also in adenocarcinoma of the bladder.